Peter J Chockley

11PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 06, 2026
CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice.

|Mar 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs.

Jorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio

|Feb 04, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.

Chiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin

|Feb 02, 2026
LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen

|Aug 05, 2024
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models.

Lindsay J Talbot, Ashley Chabot, Aaron B Ross

|Mar 14, 2023
CD47 expression is critical for CAR T-cell survival in vivo.

Alex N Beckett, Peter Chockley, Shondra M Pruett-Miller

Pageof 2

Frequent Collaborators

6 joint publications

Giedre Krenciute

5 joint publications

Stephen Gottschalk

3 joint publications

Christopher DeRenzo

3 joint publications

Charles G Mullighan